{"denoms":[{"counts":[{"groupId":"BG000","value":"320"},{"groupId":"BG001","value":"155"},{"groupId":"BG002","value":"475"}],"units":"Participants"}],"groups":[{"description":"Idelalisib 150 mg tablet twice daily + bendamustine intravenously (starting dose of 90 mg/m\\^2 for up to 12 infusions) + rituximab intravenously (375 mg/m\\^2 on Day 1 for a total of 6 infusions)","id":"BG000","title":"Idelalisib + Bendamustine + Rituximab"},{"description":"Placebo tablet twice daily + bendamustine intravenously (starting dose of 90 mg/m\\^2 for up to 12 infusions) + rituximab intravenously (375 mg/m\\^2 on Day 1 for a total of 6 infusions)","id":"BG001","title":"Placebo + Bendamustine + Rituximab"},{"description":"Total of all reporting groups","id":"BG002","title":"Total"}],"measures":[{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","spread":"10.5","value":"62"},{"groupId":"BG001","spread":"11.1","value":"62"},{"groupId":"BG002","spread":"10.9","value":"62"}]}]}],"dispersionType":"STANDARD_DEVIATION","paramType":"MEAN","title":"Age, Continuous","unitOfMeasure":"years"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"132"},{"groupId":"BG001","value":"58"},{"groupId":"BG002","value":"190"}],"title":"Female"},{"measurements":[{"groupId":"BG000","value":"188"},{"groupId":"BG001","value":"97"},{"groupId":"BG002","value":"285"}],"title":"Male"}]}],"paramType":"COUNT_OF_PARTICIPANTS","title":"Sex: Female, Male","unitOfMeasure":"Participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"26"},{"groupId":"BG001","value":"8"},{"groupId":"BG002","value":"34"}]}],"title":"Asian"},{"categories":[{"measurements":[{"groupId":"BG000","value":"2"},{"groupId":"BG001","value":"2"},{"groupId":"BG002","value":"4"}]}],"title":"Black or African American"},{"categories":[{"measurements":[{"groupId":"BG000","value":"247"},{"groupId":"BG001","value":"122"},{"groupId":"BG002","value":"369"}]}],"title":"White"},{"categories":[{"measurements":[{"groupId":"BG000","value":"4"},{"groupId":"BG001","value":"2"},{"groupId":"BG002","value":"6"}]}],"title":"Other"},{"categories":[{"measurements":[{"groupId":"BG000","value":"41"},{"groupId":"BG001","value":"21"},{"groupId":"BG002","value":"62"}]}],"title":"Not Permitted"}],"paramType":"COUNT_OF_PARTICIPANTS","title":"Race/Ethnicity, Customized","unitOfMeasure":"Participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"16"},{"groupId":"BG001","value":"8"},{"groupId":"BG002","value":"24"}]}],"title":"Hispanic or Latino"},{"categories":[{"measurements":[{"groupId":"BG000","value":"262"},{"groupId":"BG001","value":"129"},{"groupId":"BG002","value":"391"}]}],"title":"Not Hispanic or Latino"},{"categories":[{"measurements":[{"groupId":"BG000","value":"42"},{"groupId":"BG001","value":"18"},{"groupId":"BG002","value":"60"}]}],"title":"Not Permitted"}],"paramType":"COUNT_OF_PARTICIPANTS","title":"Race/Ethnicity, Customized","unitOfMeasure":"Participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"16"},{"groupId":"BG001","value":"11"},{"groupId":"BG002","value":"27"}]}],"title":"Russian Federation"},{"categories":[{"measurements":[{"groupId":"BG000","value":"37"},{"groupId":"BG001","value":"12"},{"groupId":"BG002","value":"49"}]}],"title":"United States"},{"categories":[{"measurements":[{"groupId":"BG000","value":"33"},{"groupId":"BG001","value":"20"},{"groupId":"BG002","value":"53"}]}],"title":"United Kingdom"},{"categories":[{"measurements":[{"groupId":"BG000","value":"21"},{"groupId":"BG001","value":"11"},{"groupId":"BG002","value":"32"}]}],"title":"Spain"},{"categories":[{"measurements":[{"groupId":"BG000","value":"47"},{"groupId":"BG001","value":"19"},{"groupId":"BG002","value":"66"}]}],"title":"Canada"},{"categories":[{"measurements":[{"groupId":"BG000","value":"12"},{"groupId":"BG001","value":"7"},{"groupId":"BG002","value":"19"}]}],"title":"Czech Republic"},{"categories":[{"measurements":[{"groupId":"BG000","value":"3"},{"groupId":"BG001","value":"2"},{"groupId":"BG002","value":"5"}]}],"title":"Sweden"},{"categories":[{"measurements":[{"groupId":"BG000","value":"7"},{"groupId":"BG001","value":"2"},{"groupId":"BG002","value":"9"}]}],"title":"Taiwan"},{"categories":[{"measurements":[{"groupId":"BG000","value":"25"},{"groupId":"BG001","value":"11"},{"groupId":"BG002","value":"36"}]}],"title":"Poland"},{"categories":[{"measurements":[{"groupId":"BG000","value":"10"},{"groupId":"BG001","value":"2"},{"groupId":"BG002","value":"12"}]}],"title":"Korea, Republic of"},{"categories":[{"measurements":[{"groupId":"BG000","value":"21"},{"groupId":"BG001","value":"14"},{"groupId":"BG002","value":"35"}]}],"title":"Italy"},{"categories":[{"measurements":[{"groupId":"BG000","value":"6"},{"groupId":"BG001","value":"2"},{"groupId":"BG002","value":"8"}]}],"title":"Israel"},{"categories":[{"measurements":[{"groupId":"BG000","value":"36"},{"groupId":"BG001","value":"18"},{"groupId":"BG002","value":"54"}]}],"title":"France"},{"categories":[{"measurements":[{"groupId":"BG000","value":"44"},{"groupId":"BG001","value":"23"},{"groupId":"BG002","value":"67"}]}],"title":"Australia"},{"categories":[{"measurements":[{"groupId":"BG000","value":"2"},{"groupId":"BG001","value":"1"},{"groupId":"BG002","value":"3"}]}],"title":"Germany"}],"paramType":"COUNT_OF_PARTICIPANTS","title":"Region of Enrollment","unitOfMeasure":"Participants"}],"populationDescription":"The Intent to Treat (ITT) Analysis Set: all participants who were randomized regardless of whether they received any study treatment"}